Logo image of ALTUV.PA

BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis

EPA:ALTUV - Euronext Paris - Matif - FR0013345493 - Common Stock - Currency: EUR

2.085  +0.02 (+1.21%)

Fundamental Rating

3

Taking everything into account, ALTUV scores 3 out of 10 in our fundamental rating. ALTUV was compared to 110 industry peers in the Machinery industry. Both the profitability and financial health of ALTUV have multiple concerns. ALTUV is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALTUV has reported negative net income.
ALTUV had a positive operating cash flow in the past year.
Of the past 5 years ALTUV 4 years were profitable.
In multiple years ALTUV reported negative operating cash flow during the last 5 years.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

ALTUV has a Return On Assets of -1.05%. This is in the lower half of the industry: ALTUV underperforms 72.73% of its industry peers.
ALTUV has a worse Return On Equity (-2.20%) than 69.09% of its industry peers.
ALTUV's Return On Invested Capital of 3.09% is on the low side compared to the rest of the industry. ALTUV is outperformed by 65.45% of its industry peers.
ALTUV had an Average Return On Invested Capital over the past 3 years of 3.61%. This is below the industry average of 8.45%.
Industry RankSector Rank
ROA -1.05%
ROE -2.2%
ROIC 3.09%
ROA(3y)1.43%
ROA(5y)0.84%
ROE(3y)3.37%
ROE(5y)1.86%
ROIC(3y)3.61%
ROIC(5y)N/A
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

ALTUV's Profit Margin has declined in the last couple of years.
ALTUV's Operating Margin of 4.98% is in line compared to the rest of the industry. ALTUV outperforms 42.73% of its industry peers.
ALTUV's Operating Margin has improved in the last couple of years.
ALTUV has a Gross Margin (36.33%) which is comparable to the rest of the industry.
ALTUV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.98%
PM (TTM) N/A
GM 36.33%
OM growth 3Y7.01%
OM growth 5Y113.83%
PM growth 3Y-45.76%
PM growth 5Y-4.93%
GM growth 3Y3.83%
GM growth 5Y-0.91%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

2

2. Health

2.1 Basic Checks

ALTUV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALTUV has more shares outstanding
ALTUV has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALTUV has a worse debt to assets ratio.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.51, we must say that ALTUV is in the distress zone and has some risk of bankruptcy.
ALTUV has a worse Altman-Z score (1.51) than 60.00% of its industry peers.
The Debt to FCF ratio of ALTUV is 4.67, which is a neutral value as it means it would take ALTUV, 4.67 years of fcf income to pay off all of its debts.
ALTUV's Debt to FCF ratio of 4.67 is fine compared to the rest of the industry. ALTUV outperforms 60.91% of its industry peers.
ALTUV has a Debt/Equity ratio of 0.61. This is a neutral value indicating ALTUV is somewhat dependend on debt financing.
The Debt to Equity ratio of ALTUV (0.61) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.67
Altman-Z 1.51
ROIC/WACC0.44
WACC7.04%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

ALTUV has a Current Ratio of 1.69. This is a normal value and indicates that ALTUV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.69, ALTUV is in line with its industry, outperforming 53.64% of the companies in the same industry.
ALTUV has a Quick Ratio of 1.69. This is a bad value and indicates that ALTUV is not financially healthy enough and could expect problems in meeting its short term obligations.
ALTUV's Quick ratio of 0.83 is on the low side compared to the rest of the industry. ALTUV is outperformed by 65.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 0.83
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

3

3. Growth

3.1 Past

ALTUV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -153.38%.
ALTUV shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.06% yearly.
ALTUV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.58%.
The Revenue has been growing by 28.28% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-153.38%
EPS 3Y-43.81%
EPS 5Y15.06%
EPS Q2Q%-69.42%
Revenue 1Y (TTM)-13.58%
Revenue growth 3Y10.26%
Revenue growth 5Y28.28%
Sales Q2Q%-8.41%

3.2 Future

ALTUV is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by 0.00% yearly.
The Revenue is expected to grow by 1.03% on average over the next years.
EPS Next Y-54.54%
EPS Next 2Y-4.65%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year-13.48%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.03%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

ALTUV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALTUV is valuated reasonably with a Price/Forward Earnings ratio of 10.13.
Based on the Price/Forward Earnings ratio, ALTUV is valued a bit cheaper than the industry average as 76.36% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.15. ALTUV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 10.13
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALTUV is on the same level as its industry peers.
ALTUV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALTUV is cheaper than 92.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.38
EV/EBITDA 8.65
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.65%
EPS Next 3Y0%

2

5. Dividend

5.1 Amount

ALTUV has a Yearly Dividend Yield of 2.50%.
ALTUV's Dividend Yield is a higher than the industry average which is at 3.25.
Compared to an average S&P500 Dividend Yield of 2.40, ALTUV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

ALTUV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-83.82%
EPS Next 2Y-4.65%
EPS Next 3Y0%
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

BIO-UV GROUP SAS

EPA:ALTUV (5/30/2025, 7:00:00 PM)

2.085

+0.02 (+1.21%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-03 2025-04-03/amc
Earnings (Next)09-17 2025-09-17
Inst Owners5.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.50M
Analysts86.67
Price Target3.06 (46.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP-83.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.57%
PT rev (3m)-16.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.13
P/S 0.72
P/FCF 5.38
P/OCF 4.26
P/B 0.9
P/tB N/A
EV/EBITDA 8.65
EPS(TTM)-0.07
EYN/A
EPS(NY)0.21
Fwd EY9.87%
FCF(TTM)0.39
FCFY18.6%
OCF(TTM)0.49
OCFY23.47%
SpS2.9
BVpS2.33
TBVpS-0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.05%
ROE -2.2%
ROCE 3.84%
ROIC 3.09%
ROICexc 3.3%
ROICexgc 12.94%
OM 4.98%
PM (TTM) N/A
GM 36.33%
FCFM 13.35%
ROA(3y)1.43%
ROA(5y)0.84%
ROE(3y)3.37%
ROE(5y)1.86%
ROIC(3y)3.61%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)15.38%
ROICexgc(5y)N/A
ROCE(3y)4.5%
ROCE(5y)N/A
ROICexcg growth 3Y20.27%
ROICexcg growth 5Y91.44%
ROICexc growth 3Y0.06%
ROICexc growth 5Y106.94%
OM growth 3Y7.01%
OM growth 5Y113.83%
PM growth 3Y-45.76%
PM growth 5Y-4.93%
GM growth 3Y3.83%
GM growth 5Y-0.91%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.67
Debt/EBITDA 3.39
Cap/Depr 37.07%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 116.85%
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 0.83
Altman-Z 1.51
F-Score4
WACC7.04%
ROIC/WACC0.44
Cap/Depr(3y)75.44%
Cap/Depr(5y)101.31%
Cap/Sales(3y)5.68%
Cap/Sales(5y)7.19%
Profit Quality(3y)1175.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-153.38%
EPS 3Y-43.81%
EPS 5Y15.06%
EPS Q2Q%-69.42%
EPS Next Y-54.54%
EPS Next 2Y-4.65%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.58%
Revenue growth 3Y10.26%
Revenue growth 5Y28.28%
Sales Q2Q%-8.41%
Revenue Next Year-13.48%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
EBIT growth 1Y-29.85%
EBIT growth 3Y18%
EBIT growth 5Y174.31%
EBIT Next Year41.32%
EBIT Next 3Y23.12%
EBIT Next 5YN/A
FCF growth 1Y315.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100.1%
OCF growth 3YN/A
OCF growth 5YN/A